Clinical Trial Update: Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of apixaban for extended treatment of deep vein thrombosis or pulmonary embolism; results posted for a complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Venous Thrombosis | Phase 3 | Status: COMPLETED | Results posted: 2013-10-25